VentriPoint Diagnostics Ltd
XTSX:VPT
VentriPoint Diagnostics Ltd
Research & Development
VentriPoint Diagnostics Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
VentriPoint Diagnostics Ltd
XTSX:VPT
|
Research & Development
-CA$476k
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Research & Development
-$21m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-19%
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Research & Development
-CA$2.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
|
MedMira Inc
XTSX:MIR
|
Research & Development
-CA$965.6k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
3%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Research & Development
-CA$9.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Research & Development
-$15.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
6%
|
|
VentriPoint Diagnostics Ltd
Glance View
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in North York, Ontario. The company went IPO on 2005-11-09. The firm offers Ventripoint Medical System (VMS) equipment. The firm's VMS+ is a diagnostic aid, which is developed to provide a point-of care solution to communicate the heart's structure and function without the need for magnetic resonance imaging (MRI). Its VMS+ is designed to create a three-dimensional (3D) model of the heart from a two-dimensional (2D) echocardiogram and allows cardiac metrics on all four chambers of the heart within minutes. The firm enables VMS+ software to be installed on any personal workstation. The Company’s Knowledge Based Reconstruction (KBR) enables to construct a 3D model of the heart and calculates volumes and ejection fractions for all chambers. The firm has not generated any revenues.
See Also
What is VentriPoint Diagnostics Ltd's Research & Development?
Research & Development
-476k
CAD
Based on the financial report for Sep 30, 2025, VentriPoint Diagnostics Ltd's Research & Development amounts to -476k CAD.
What is VentriPoint Diagnostics Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
17%
Over the last year, the Research & Development growth was 52%. The average annual Research & Development growth rates for VentriPoint Diagnostics Ltd have been 17% over the past three years .
